2024 BrainChip Discussion, page-6616

Their agenda and/or position will see them denying in the face of overwhelming evidence that the value of BRN is underpinned by their portfolio of patents.
What evidence do they ever produce to back up their claims??
Forecasts of AI at the Edge is for exponential growth.
The Pitt Street research puts the value at around $1.59 per share without revenue.
Once revenue starts rolling in, the $1.59 will be smashed in no time.
Revenue later is the icing on the cake. The patents are the holders' safety net.
In the meantime, we just have to use downramper posts as a good opportunity to respond outlining such things as patent value, forecast industry growth, partnerships, new developments, etc.
Downrampers are just another part of the landscape pushing their own agendas. The patent value alone will eventually see them off, kicking and screaming to the bitter end.
They actually provide good opportunities to respond with positives.
We are getting closer to deals, so their posts are becoming very 'brush off' or 'laugh off'.
Remember, its agenda not personal for downrampers, and their strategy is to make it personal for holders and to get them to start doubting their position.